Hypothesis

16 Matching Annotations

Last 7 days
www.sciencedirect.com www.sciencedirect.com

Neuronal differentiation of neuroblastoma cell lines for neurological disease modeling

1
1. scibot 22 Jun 2026
  
  in Public
  
  RRID:CVCL_1232
  
  DOI: 10.1016/j.isci.2026.116469
  
  Resource: (RRID:CVCL_1232)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004226018444
Apr 2026
aacrjournals.org aacrjournals.org

Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers

1
1. scibot 23 Apr 2026
  
  in Public
  
  RRID:CVCL_1232
  
  DOI: 10.1158/2159-8290.CD-24-1738
  
  Resource: (RRID:CVCL_1232)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

aacrjournals.org/cancerdiscovery/article/15/10/2054/765955/Extrachromosomal-DNA-Driven-Oncogene-Dosage
Jan 2026
www.biorxiv.org www.biorxiv.org

Reverse molecular pharmacology identifies the non-canonical axis of IRAK as a chemoresistance factor in neuroblastoma

1
1. scibot 13 Jan 2026
  
  in Public
  
  RRID:CVCL_1232
  
  DOI: 10.64898/2026.01.09.697473
  
  Resource: (RRID:CVCL_1232)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

biorxiv.org/content/10.64898/2026.01.09.697473v1
Jan 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma

2
1. scibot 30 Jan 2025
  
  in Public
  
  RRID: CVCL_1232
  
  DOI: 10.1158/2767-9764.CRC-24-0569
  
  Resource: (RRID:CVCL_1232)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
2. scibot 30 Jan 2025
  
  in Public
  
  RRID:CVCL_1232
  
  DOI: 10.1158/2767-9764.CRC-24-0569
  
  Resource: (RRID:CVCL_1232)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC11774142/
Aug 2024
www.biorxiv.org www.biorxiv.org

L-glyceraldehyde inhibits neuroblastoma cell growth via a multi-modal mechanism on metabolism and signaling

1
1. scibot 13 Aug 2024
  
  in Public
  
  RRID: CVCL_1232
  
  DOI: 10.1101/2023.12.20.572547
  
  Resource: (RRID:CVCL_1232)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

biorxiv.org/content/10.1101/2023.12.20.572547v2
Jul 2024
febs.onlinelibrary.wiley.com febs.onlinelibrary.wiley.com

FEBS Press

1
1. scibot 23 Jul 2024
  
  in Public
  
  RRID:CVCL_1232
  
  DOI: 10.1002/1878-0261.13702
  
  Resource: (ICLC Cat# HTL98011, RRID:CVCL_1232)
  
  Curator: @dhovakimyan1
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.13702
May 2024
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

L-Glyceraldehyde Inhibits Neuroblastoma Cell Growth via a Multi-Modal Mechanism on Metabolism and Signaling

1
1. scibot 15 May 2024
  
  in Public
  
  RRID:CVCL_1232
  
  DOI: 10.3390/cancers16091664
  
  Resource: (ICLC Cat# HTL98011, RRID:CVCL_1232)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC11083149/
Sep 2023
www.sciencedirect.com www.sciencedirect.com

Palbociclib releases the latent differentiation capacity of neuroblastoma cells

1
1. scibot 30 Sep 2023
  
  in Public
  
  CVCL_1232
  
  DOI: 10.1016/j.devcel.2023.08.028
  
  Resource: (ICLC Cat# HTL98011, RRID:CVCL_1232)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1534580723004434
Jul 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors

1
1. scibot 19 Jul 2023
  
  in Public
  
  RRID:CVCL_1232
  
  DOI: 10.1158/0008-5472.CAN-21-4309
  
  Resource: (ICLC Cat# HTL98011, RRID:CVCL_1232)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9938728/
Apr 2022
aacrjournals.org aacrjournals.org

Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

1
1. scibot 07 Apr 2022
  
  in Public
  
  RRID:CVCL_1232
  
  DOI: 10.1158/1078-0432.CCR-20-3044
  
  Resource: (ICLC Cat# HTL98011, RRID:CVCL_1232)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

aacrjournals.org/clincancerres/article/27/5/1438/83571/Targeted-Therapy-of-TERT-Rearranged-Neuroblastoma
Mar 2022
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Selective modulation of a pan-essential protein as a therapeutic strategy in cancer

1
1. scibot 04 Mar 2022
  
  in Public
  
  CVCL_1232
  
  DOI: 10.1158/2159-8290.CD-20-1213
  
  Resource: (ICLC Cat# HTL98011, RRID:CVCL_1232)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8419012/
May 2021
onlinelibrary.wiley.com onlinelibrary.wiley.com

Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma

1
1. scibot 20 May 2021
  
  in Public
  
  RRID: CVCL_1232
  
  DOI: 10.1002/ijc.33423
  
  Resource: (ICLC Cat# HTL98011, RRID:CVCL_1232)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

onlinelibrary.wiley.com/doi/10.1002/ijc.33423
Sep 2020
www.sciencedirect.com www.sciencedirect.com

Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2

1
1. scibot 14 Sep 2020
  
  in Public
  
  RRID:CVCL_1232
  
  DOI: 10.1016/j.cell.2020.03.051
  
  Resource: (ICLC Cat# HTL98011, RRID:CVCL_1232)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRIDCUR:Validated RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

RRIDCUR:Validated

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867420303445
Aug 2020
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against MYCN-Amplified Neuroblastoma

1
1. scibot 20 Aug 2020
  
  in Public
  
  RRID:CVCL_1232
  
  DOI: 10.3389/fonc.2020.00818
  
  Resource: (ICLC Cat# HTL98011, RRID:CVCL_1232)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232
Visit annotations in context

Tags

RRID:CVCL_1232

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC7269128/
Jan 2020
onlinelibrary.wiley.com onlinelibrary.wiley.com

Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model

1
1. scibot 13 Jan 2020
  
  in Public
  
  RRID:CVCL_1232
  
  DOI: 10.1002/ijc.32572
  
  Resource: (ICLC Cat# HTL98011, RRID:CVCL_1232)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_1232
  
  What is this?
  
  RRID:CVCL_1232 RRIDCUR:Validated
Visit annotations in context

Tags

RRID:CVCL_1232

RRIDCUR:Validated

Annotators

scibot

URL

onlinelibrary.wiley.com/doi/10.1002/ijc.32572